The impact of the Gly482Ser polymorphism in PPARGC1A on body composition and glucose tolerance, as well as insulin sensitivity and secretion, was demonstrated in a Finnish study of nondiabetic offspring of patients with type 2 diabetes. The gene discussed is INS; the disease is type 2 diabetes mellitus.